At the forefront of research and care

Currently, the laboratory performs approximately 14,000 procedures per year, including over 5,000 interventional procedures. These involve angioplasty, rotational atherectomy, intracoronary stenting, drug-eluting stent, thrombectomy, valvuloplasty and peripheral vascular interventions. The Cath Lab is also involved in numerous FDA-approved protocols and studies involving newer stents, medications to decrease reblockage, clot-busting drugs, and gene therapy to grow new vessels in the heart, just to name some of its current developments.

The Cath Lab's reputation for safely performing a difficult procedure known as "rotational atherectom" that is used for tough calcified lesions as well as balloon aortic valvuloplasty for elderly non-operable patients is well known and greatly respected. Many regional medical centers and physicians refer complex and difficult coronary and valvular cases to Mount Sinai Heart's Cath Lab.